Modest Pain Relief from Dronabinol in MS Patients

Does pain associated with plaque lesions that affect central pain pathways in patients with multiple sclerosis (MS) respond to cannabinoids? To find out, investigators randomized 24 patients with MS and central pain to receive either dronabinol (δ-9-tetrahydrocannabinol [THC]; maximum dose, 10 mg/day) or placebo orally for 3 weeks, followed by a …